Abnormal Expression of TFIIIB Subunits and RNA Pol III Genes is Associated with Hepatocellular Carcinoma

Overview

Journal Liver Res

Date 2017 Dec 26

PMID 29276645

Citations 12

Authors

Junxia Lei

Songlin Chen

Shuping Zhong

Affiliations

Soon will be listed here.

Abstract

The levels of the products of RNA polymerase III-dependent genes (Pol III genes), including tRNAs and 5S rRNA, are elevated in transformed and tumor cells, which potentiate tumorigenesis. TFIIB-related factor 1 (Brf1) is a key transcription factor and specifically regulates the transcription of Pol III genes. and studies have demonstrated that a decrease in Brf1 reduces Pol III gene transcription and is sufficient for inhibiting cell transformation and tumor formation. Emerging evidence indicates that dysregulation of Brf1 and Pol III genes is linked to the development of hepatocellular carcinoma (HCC) in humans and animals. We have reported that Brf1 is overexpressed in human liver cancer patients and that those with high Brf1 levels have shorter survivals. This review summarizes the effects of dysregulation of these genes on HCC and their regulation by signaling pathways and epigenetics. These novel data should help us determine the molecular mechanisms of HCC from a different perspective and guide the development of therapeutic approaches for HCC patients.

Citing Articles

Downregulation of Brf1 Induces Liver Failure and Inhibits Hepatocellular Carcinoma Progression by Promoting Apoptosis.

Xu Y, Yu C, Zhang H, Wang T, Liu Y, Wu L J Cancer. 2024; 15(17):5577-5593.

PMID: 39308682 PMC: 11414613. DOI: 10.7150/jca.97277.

STAT3 promotes RNA polymerase III-directed transcription by controlling the miR-106a-5p/TP73 axis.

Zhang C, Zhao S, Deng H, Zhang S, Wang J, Song X Elife. 2023; 12.

PMID: 36656267 PMC: 9851613. DOI: 10.7554/eLife.82826.

Transcriptional factor III A promotes colorectal cancer progression by upregulating cystatin A.

Wang J, Tan Y, Jia Q, Tang F World J Gastrointest Oncol. 2022; 14(10):1918-1932.

PMID: 36310710 PMC: 9611429. DOI: 10.4251/wjgo.v14.i10.1918.

Early Growth Response 1 Strengthens Pol-III-Directed Transcription and Transformed Cell Proliferation by Controlling PTEN/AKT Signalling Activity.

Wu Z, Huang L, Zhao S, Wang J, Zhang C, Song X Int J Mol Sci. 2022; 23(9).

PMID: 35563324 PMC: 9105817. DOI: 10.3390/ijms23094930.

ROS Signaling-Mediated Novel Biological Targets: Brf1 and RNA Pol III Genes.

Zheng L, Lin Y, Zhong S Oxid Med Cell Longev. 2021; 2021:5888432.

PMID: 34646425 PMC: 8505076. DOI: 10.1155/2021/5888432.

References

Goodfellow S, Innes F, Derblay L, MacLellan W, Scott P, White R . Regulation of RNA polymerase III transcription during hypertrophic growth. EMBO J. 2006; 25(7):1522-33. PMC: 1440310. DOI: 10.1038/sj.emboj.7601040. View

Brunmeir R, Lagger S, Simboeck E, Sawicka A, Egger G, Hagelkruys A . Epigenetic regulation of a murine retrotransposon by a dual histone modification mark. PLoS Genet. 2010; 6(4):e1000927. PMC: 2861705. DOI: 10.1371/journal.pgen.1000927. View

Zhong S, Machida K, Tsukamoto H, Johnson D . Alcohol induces RNA polymerase III-dependent transcription through c-Jun by co-regulating TATA-binding protein (TBP) and Brf1 expression. J Biol Chem. 2010; 286(4):2393-401. PMC: 3024733. DOI: 10.1074/jbc.M110.192955. View

Shi G, Zhong S . Alcohol-associated cancer and deregulation of Pol III genes. Gene. 2016; 612:25-28. PMC: 5374039. DOI: 10.1016/j.gene.2016.09.046. View

Derijard B, Hibi M, Wu I, Barrett T, Su B, Deng T . JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 1994; 76(6):1025-37. DOI: 10.1016/0092-8674(94)90380-8. View

Kenneth N, Ramsbottom B, Gomez-Roman N, Marshall L, Cole P, White R . TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. Proc Natl Acad Sci U S A. 2007; 104(38):14917-22. PMC: 1986588. DOI: 10.1073/pnas.0702909104. View

Tsuiki H, Tnani M, Okamoto I, Kenyon L, Emlet D, Holgado-Madruga M . Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors. Cancer Res. 2003; 63(1):250-5. View

Kallunki T, Su B, Tsigelny I, Sluss H, Derijard B, Moore G . JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 1994; 8(24):2996-3007. DOI: 10.1101/gad.8.24.2996. View

Watanabe T, Tanaka G, Hamada S, Namiki C, Suzuki T, Nakajima M . Dose-dependent alterations in gene expression in mouse liver induced by diethylnitrosamine and ethylnitrosourea and determined by quantitative real-time PCR. Mutat Res. 2008; 673(1):9-20. DOI: 10.1016/j.mrgentox.2008.11.004. View

10.

Majello B, Napolitano G, De Luca P, Lania L . Recruitment of human TBP selectively activates RNA polymerase II TATA-dependent promoters. J Biol Chem. 1998; 273(26):16509-16. DOI: 10.1074/jbc.273.26.16509. View

11.

Hirsch H, Jawdekar G, Lee K, Gu L, Henry R . Distinct mechanisms for repression of RNA polymerase III transcription by the retinoblastoma tumor suppressor protein. Mol Cell Biol. 2004; 24(13):5989-99. PMC: 480882. DOI: 10.1128/MCB.24.13.5989-5999.2004. View

12.

Barski A, Chepelev I, Liko D, Cuddapah S, Fleming A, Birch J . Pol II and its associated epigenetic marks are present at Pol III-transcribed noncoding RNA genes. Nat Struct Mol Biol. 2010; 17(5):629-34. PMC: 2917008. DOI: 10.1038/nsmb.1806. View

13.

Naugler W, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy A . Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007; 317(5834):121-4. DOI: 10.1126/science.1140485. View

14.

Wang Z, Zang C, Rosenfeld J, Schones D, Barski A, Cuddapah S . Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet. 2008; 40(7):897-903. PMC: 2769248. DOI: 10.1038/ng.154. View

15.

Woiwode A, Johnson S, Zhong S, Zhang C, Roeder R, Teichmann M . PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex. Mol Cell Biol. 2008; 28(12):4204-14. PMC: 2423115. DOI: 10.1128/MCB.01912-07. View

16.

Engelberg D . Stress-activated protein kinases-tumor suppressors or tumor initiators?. Semin Cancer Biol. 2004; 14(4):271-82. DOI: 10.1016/j.semcancer.2004.04.006. View

17.

Zhong Q, Shi G, Zhang Y, Levy D, Zhong S . Elk1 and AP-1 sites in the TBP promoter mediate alcohol-induced deregulation of Pol III-dependent genes. Gene. 2013; 526(1):54-60. PMC: 3715583. DOI: 10.1016/j.gene.2013.02.004. View

18.

Schramm L, Hernandez N . Recruitment of RNA polymerase III to its target promoters. Genes Dev. 2002; 16(20):2593-620. DOI: 10.1101/gad.1018902. View

19.

Oler A, Alla R, Roberts D, Wong A, Hollenhorst P, Chandler K . Human RNA polymerase III transcriptomes and relationships to Pol II promoter chromatin and enhancer-binding factors. Nat Struct Mol Biol. 2010; 17(5):620-8. PMC: 2945309. DOI: 10.1038/nsmb.1801. View

20.

Seligson D, Horvath S, Shi T, Yu H, Tze S, Grunstein M . Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005; 435(7046):1262-6. DOI: 10.1038/nature03672. View